philanthropy.org | 990 Resource | FAQ Verify yourself Sign in
DP
Person · officer / director

Dr Peter Jones

Chief Scientific Officer & Res. Dir. · Van Andel Research Institute

Chief Scientific Officer & Res. Dir. at Van Andel Research Institute. Listed as an officer, director, or key employee across 2 organizations on the Form 990 record.

Organizations
2
Roles reported
2
Reported compensation
$953K

Who this is

Profile

Everything on the left is verified from the IRS filings. The biography on the right is compiled from public web sources and grounded to that filed record.

✓ Verified from filings
●
Reported as Chief Scientific Officer & Res. Dir. of Van Andel Research Institute, based in Grand Rapids, MI.
●
Received $953K in total reported compensation on the most recent Form 990 (Part VII).
●
Also listed as Vaigs Director, Vari Cso of Van Andel Institute Graduate School, uncompensated.
Facts extracted directly from each organization's Form 990, Part VII.
Biography Web-sourced

Peter A. Jones is Chief Scientific Officer of Van Andel Research Institute in Grand Rapids, Michigan, and served as President from 2024 to 2026.

A pioneering cancer epigenetics researcher, he previously directed the USC Norris Comprehensive Cancer Center (1993–2011) and is a fellow of the National Academy of Medicine.

Compiled from public web sources (4 cited), grounded to the filed record.

Track record

Career & tenure

Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.

Tenure here
Chief Scientific Officer, 2014–2026; President, 2024–2026

Affiliations

Organizations

Linked as the same person by IRS Schedule R, a shared officer mailing address, or shared fellow board members.

Van Andel Research Institute Chief Scientific Officer & Res. Dir. · $112.7M revenue · Grand Rapids, MIMEDICAL RESEARCH ORGANIZATIONpay $753K → $953KFiled FY2023, FY2022, FY2021, FY2020, FY2019 · Source: Form 990, Part VII
$953Kreported comp
Van Andel Institute Graduate School Vaigs Director, Vari Cso · $1.4M revenue · Grand Rapids, MITO DEVELOP BIOMEDICAL RESEARCH LEADERS THROUGH A GRADUATE PROGRAM IN MOLECULAR AND CELL BIOLOGY.Filed FY2023, FY2022, FY2021 · Source: Form 990, Part VII

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

K
Chief Investment Officer · FY2023
$1.1M
T
Assoc Direct-Sr. Portfolio Mgr. · FY2023
$782K
D
Chairman / CEO · FY2023
$692K
D
Chief Operat. Officer (end 4/1/2024) · FY2023
$636K
D
Associate Research Director · FY2021
$536K
A
Senior Portfolio Manager · FY2023
$530K
T
General Counsel · FY2023
$518K
D
Distinguished Investigator · FY2023
$514K
G
Chief Strat. Officer (end 7/5/2024) · FY2023
$508K
T
Vice President & CAO/CFO · FY2023
$493K
D
Sr. Scientific Investigator · FY2022
$439K
D
Sr. Scientific Investigator & Dept. Chair · FY2023
$434K

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

Dana-Farber Cancer Institute INC$3.5B revenue · Boston, MA
American Association for Cancer Research INC$129.5M revenue · Philadelphia, PA
The Institute for Cancer Research$94.5M revenue · Philadelphia, PA

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

C
Former CEO · Sanford Burnham Prebys Medical Discovery Institute
$5.0M
L
Trustee, President, and CEO · Dana-Farber Cancer Institute
$3.7M
D
VP & Chief Investment Officer · Howard Hughes Medical Institute
$3.6M
D
CEO (thru 12/31/2022) · Transcelerate Biopharma INC
$2.6M
K
President · Sanford Burnham Prebys Medical Discovery Institute
$2.6M
L
President & CEO · Jackson Laboratory
$2.5M
Public data from IRS Form 990 e-file & the Business Master File. Individuals appear here because they were named as an officer, director, or key employee on a nonprofit's Form 990; people are grouped by name plus corroborating evidence (Schedule R, shared address, shared board members). · philanthropy.org